| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/22/2008 | US7402299 Intracorporeal medicaments for photodynamic treatment of disease |
| 07/22/2008 | CA2526385C Continuous dosing regimen with abt-751 |
| 07/22/2008 | CA2481246C Compounds that modulate ppar activity and methods for their preparation |
| 07/22/2008 | CA2474511C Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders |
| 07/22/2008 | CA2458932C Methylene-4-azasteroids |
| 07/22/2008 | CA2457056C Pharmaceutical compositions comprising polysaccharide conjugates for inhibiting the metastasis or preventing the recurrence of malignant tumor |
| 07/22/2008 | CA2446195C Processes and apparatus for extraction of active substances and enriched extracts from natural products |
| 07/22/2008 | CA2436942C Method of manufacturing substance gm-95 |
| 07/22/2008 | CA2417825C 6.alpha., 9.alpha.-difluoro-17.alpha.-`(2-furanylcarboxyl)oxy!-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 07/22/2008 | CA2396145C Osmotic device containing pseudoephedrine and an h1 antagonist |
| 07/22/2008 | CA2388076C Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
| 07/22/2008 | CA2384911C Method for the screening of .alpha.2. delta.-1 subunit binding ligands |
| 07/22/2008 | CA2383011C Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate |
| 07/22/2008 | CA2372840C Substituted bicyclic compounds |
| 07/22/2008 | CA2372270C C-2 modified erythromycin derivatives |
| 07/22/2008 | CA2368614C Improved cancer treatment with temozolomide |
| 07/22/2008 | CA2366922C Formulations for detecting asthma |
| 07/22/2008 | CA2320039C Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the preparation of medicines intended to reduce hyperglycaemia |
| 07/22/2008 | CA2313638C Cyclohexene carboxylates as neuraminidase inhibitors |
| 07/22/2008 | CA2310748C Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferation |
| 07/22/2008 | CA2289017C The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer |
| 07/22/2008 | CA2283830C Composition for forming solid particles |
| 07/22/2008 | CA2280773C Methods for the administration of amifostine |
| 07/22/2008 | CA2278328C Antifungal nail lacquer and method using same |
| 07/22/2008 | CA2278223C 1,4-dihydropyridin derivatives and their use in therapy |
| 07/22/2008 | CA2272466C Compositions containing an antifungal and a phospholipid |
| 07/22/2008 | CA2268411C Bis(acridinecarboxamide) and bis(phenazinecarboxamide) as antitumour agents |
| 07/22/2008 | CA2265095C Pyrazolopyrimidines and pyrazolotriazines |
| 07/22/2008 | CA2248841C Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy |
| 07/22/2008 | CA2238171C Quinoline derivatives as nk3 antagonists |
| 07/22/2008 | CA2222544C Site specific binding system, imaging compositions and methods |
| 07/22/2008 | CA2198916C Delivery of solid drug compositions |
| 07/22/2008 | CA2196801C Novel vaccine adjuvant and vaccine |
| 07/22/2008 | CA2186673C The use of fatty acids in the treatment of huntington's chorea |
| 07/19/2008 | CA2618704A1 Compositions containing retinoid and chromenone derivatives |
| 07/19/2008 | CA2574531A1 Hat acetylation promoters and uses of compositions thereof in promoting immunogenicity |
| 07/17/2008 | WO2008086483A2 Modulation of neurogenesis with use of modafinil |
| 07/17/2008 | WO2008086462A2 AMINO-SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF β-CANTENIN/TCF-4 PATHWAY AND CANCER TREATMENT AGENTS |
| 07/17/2008 | WO2008086409A1 5-furopyridinone substituted indazoles |
| 07/17/2008 | WO2008086404A1 5-pyridinone substituted indazoles |
| 07/17/2008 | WO2008086403A1 Chromones as therapeutic agents |
| 07/17/2008 | WO2008086353A1 Propargyl-containing derivatives of tetrahydro-benzthiazoles and methods of making and using the same |
| 07/17/2008 | WO2008086341A1 Methods. compositions, and formulations for preventing or reducing adverse effects in a patient |
| 07/17/2008 | WO2008086270A2 Ophthalmic and contact lens solutions containing forms of vitamin b |
| 07/17/2008 | WO2008086203A1 Use of reversible inhibitors of s-adenosyl-l-homocysteine hydrolase for treating lupus |
| 07/17/2008 | WO2008086188A2 Thiophene carboxamides as factor xa inhibitors |
| 07/17/2008 | WO2008086176A2 Topical pharmaceutical formulation comprising an inos inhibitor for the treatment of disease |
| 07/17/2008 | WO2008086158A1 Benzodihydroquinazoline as pi3 kinase inhibitors |
| 07/17/2008 | WO2008086131A1 Naphthylmethylimidizoles as therapeutic agents |
| 07/17/2008 | WO2008086128A2 Aminopyrazole kinase inhibitors |
| 07/17/2008 | WO2008086122A2 Imidazole derivatives as kinesin spindle protein inhibitors (eg-5) |
| 07/17/2008 | WO2008086096A2 Myocardial perfusion imaging |
| 07/17/2008 | WO2008086069A1 Methods of treating itch |
| 07/17/2008 | WO2008086053A1 Hcv inhibitors |
| 07/17/2008 | WO2008086047A1 Rho kinase inhibitors |
| 07/17/2008 | WO2008086023A1 Use of agglomerated hydroxyethylcellulose in pharmaceutical, personal care and household care applications |
| 07/17/2008 | WO2008086014A2 Bis-aryl amide derivatives useful for the treatment of cancer |
| 07/17/2008 | WO2008086008A1 Method of treating multidrug resistant cancers |
| 07/17/2008 | WO2008086005A1 Compositions including triciribine and bortezomib and derivatives thereof and methods of use thereof |
| 07/17/2008 | WO2008085995A1 Anthelmintic flavones from struthiola argenta |
| 07/17/2008 | WO2008085921A2 Methods for reduction of adipose tissue mass |
| 07/17/2008 | WO2008085913A1 Methods for treating, preventing, or reducing the risk of opthalmic, otic, and nasal infections |
| 07/17/2008 | WO2008085875A2 R-zileuton for use in conditions associated with increased 5-lipoxygenase and/or leukotriene activity (eg asthma) |
| 07/17/2008 | WO2008085872A1 Cicletanine and pkc inhibitors in the treatment of pulmonary and cardiac disorders |
| 07/17/2008 | WO2008085808A2 Method of treating hyperesthesia, paresthesia, dolor, and pruritus caused by insect stings or noxious weeds or plants using avermectin compound |
| 07/17/2008 | WO2008085728A2 Combination medication for treating the effects of stomach acid reduction medication on bone integrity |
| 07/17/2008 | WO2008085688A1 Compositions and methods for cancer treatment using a chemically linked phosphonoformic acid partial ester |
| 07/17/2008 | WO2008085674A1 Pharmaceutical compositions comprising celecoxib co-crystals |
| 07/17/2008 | WO2008085611A2 Designer theraphy of pancreatic tumors |
| 07/17/2008 | WO2008085610A1 Use of iap inhibitors for the treatment of acute myeloid leukemia |
| 07/17/2008 | WO2008085608A1 Compounds and compositions as channel activating protease inhibitors |
| 07/17/2008 | WO2008085567A1 Methods of using low-dose doxepin for the improvement of sleep |
| 07/17/2008 | WO2008085509A1 Bicyclic spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| 07/17/2008 | WO2008085508A2 Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection |
| 07/17/2008 | WO2008085506A1 3-substituted-[1,2,3]-benzotriazinone compound for enhancing glutamatergic synaptic responses |
| 07/17/2008 | WO2008085505A1 3-substituted-[1,2,3]benzotriazinone compounds for enhancing glutamatergic synaptic responses |
| 07/17/2008 | WO2008085492A2 Methods and compositions for modulating bk channel activity and vasodilation |
| 07/17/2008 | WO2008085484A2 Treatment of inflammatory bowel disease with enteric coated formulations comprising 5-aminosalicylic acid or 4-aminosalicylic acid |
| 07/17/2008 | WO2008085446A2 Antimicrobial compositions |
| 07/17/2008 | WO2008085392A1 Methods for treating nasal congestion in hepatically impaired patients |
| 07/17/2008 | WO2008085317A1 Benzazepine compounds as cgrp receptor antagonists |
| 07/17/2008 | WO2008085316A1 Bipiperidinyl compounds, compositions containing such compounds and methods of treatment |
| 07/17/2008 | WO2008085310A2 Effervescent formulations of florfenicol for addition in drinking water systems |
| 07/17/2008 | WO2008085302A1 Imidazopyridine analogs as cb2 receptor modulators, useful in the treatment of pain, respiratory and non-respiratory diseases |
| 07/17/2008 | WO2008085301A1 Silylated piperidine derivatives |
| 07/17/2008 | WO2008085300A1 Anti-hypercholesterolemic compounds |
| 07/17/2008 | WO2008085281A1 Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate |
| 07/17/2008 | WO2008085216A1 Therapeutic hpph dosage for pdt |
| 07/17/2008 | WO2008085215A1 Treatment of barrett's esophagus using photodynamic therapy |
| 07/17/2008 | WO2008085214A2 Treatment of esophageal high grade dysplasia using photodynamic therapy |
| 07/17/2008 | WO2008085119A1 New pyridine analogues viii 518 |
| 07/17/2008 | WO2008085118A1 Pyridine compounds and their use as p2y12 antagonists. |
| 07/17/2008 | WO2008085117A1 Pyridine compounds and their use as p2y12 antagonists. |
| 07/17/2008 | WO2008085074A2 1, 3-dihydroimidazoles for treating cardiovascular disorders |
| 07/17/2008 | WO2008085019A1 A method for lowering risk of cardiovascular diseases |
| 07/17/2008 | WO2008085008A1 T-cell inhibiting compounds and their use for the treatment of t-cell-mediated diseases |
| 07/17/2008 | WO2008084962A1 THIAZOLE COMPOUND (AS PPARδ) LIGAND AND PHARMACEUTICAL, COSMETIC AND HEALTH FOOD COMPRISED THEREOF |
| 07/17/2008 | WO2008084873A1 Oxime derivative |
| 07/17/2008 | WO2008084872A1 Hydrazone derivative |
| 07/17/2008 | WO2008084864A1 Capsaicin receptor activator and apparatus for spraying the same |